Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations (ImmunoTarget) Meeting Abstract
| Authors: | Mazieres, J.; Drilon, A. E.; Mhanna, L.; Milia, J.; Lusque, A.; Cortot, A. B.; Mezquita, L.; Thai, A.; Couraud, S.; Veillon, R.; Mascaux, C.; Schouten, R.; Neal, J. W.; Ng, T. L.; Frueh, M.; Peled, N.; Gounant, V.; Popat, S.; Zhu, V. W.; Gautschi, O. |
| Abstract Title: | Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations (ImmunoTarget) |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 462s |
| Language: | English |
| ACCESSION: | WOS:000442916003184 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.9010 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9010 -- Source: Wos |
